KAREN NOVAK: Open Payments
NPI 1831162411 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 7 payments from 4 companies in 2025. Trend: 2023 $465 · 2024 $315 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $71 |
| GlaxoSmithKline, LLC. | 2 | $61 |
| ABBVIE INC. | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: LYNPARZA, ELAHERE, JEMPERLI, ZEJULA, KEYTRUDA.
Industry payments across IL — which companies pay providers there.
